BFS
AVNS

Bradley Foster & Sargent’s Avanos Medical AVNS Stock Holding History

Bradley Foster & Sargent’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,326
Closed -$237K – 333
2015
Q3 		$237K Sell
8,326
-8,962
-52% -$313K 0.01% 305
2015
Q2 		$700K Sell
17,288
-5,089
-23% -$228K 0.03% 230
2015
Q1 		$1.1M Buy
22,377
+9,783
+78% +$453K 0.05% 187
2014
Q4 		$573K Buy
+12,594
New +$495K 0.03% 236

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Bradley Foster & Sargent's AVNS Position: Q4 2015 in Review

Bradley Foster & Sargent sold out of Avanos Medical (AVNS) in Q4 2015, closing a stake of 8,326 shares — an estimated $237K sold.

Bradley Foster & Sargent first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $1.1M in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2015.

  • Bradley Foster & Sargent reported no remaining Avanos Medical position as of Q4 2015 after selling out during the quarter.
  • Bradley Foster & Sargent sold 8,326 Avanos Medical shares in Q4 2015, an estimated $237K.
  • Bradley Foster & Sargent first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
  • Bradley Foster & Sargent's Avanos Medical position peaked at $1.1M in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2015.

Based on Bradley Foster & Sargent's 13F filing for Q4 2015, filed 5 Feb 2016.